Search tips
ECCMID 2023
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
16 April 2023 - O0688
Interim safety and immunogenicity results of a bivalent SARS-CoV-2 Omicron booster vaccine: a phase 3, randomised, observer-blind, active-controlled trial
Ivan Lee, Catherine A. Cosgrove, Patrick Moore, Marcin Bula, Philip Kalra, Paul Dargan, Rebecca Clark, Marta Boffito, Ray Sheridan, Claire Bethune, Fiona Burns, Dinesh Saralaya, Rhiannon Nally, Christopher J. A. Duncan, David Chadwick, Adrian Palfreeman, Alberto San Francisco Ramos, Paul T. Heath, Bethany Girard, Christy Parker, Dondi Rust, Shraddha Mehta, Elizabeth De Windt, Andrea Sutherland, Laree Tracy, Honghong Zhou, Jacqueline Miller, Rituparna Das
16 April 2019 - P2221
Seven years of candidaemia (2011-2017) in a Madrid tertiary hospital
Ana Gonzalez Gonzalez, Carolina Navarro San Francisco, Ana Maria Sanchez Diaz, Francesca Gioia, Jesus Fortun Abete, Elena Loza, Rafael Canton Moreno, Elia García G. De La Pedrosa, Juan de Dios Caballero Pérez
16 April 2019 - P2175
Microsatellite markers for the characterisation of Candida parapsilosis candidaemia isolates recovered in a tertiary care hospital
Ana Gonzalez Gonzalez, Carolina Navarro San Francisco, Beatriz Romero, Rosa Del Campo, Dolores Telleria, Marta Cobo, Elena Loza, Rafael Canton Moreno, Elia García G. De La Pedrosa, Juan de Dios Caballero Pérez
24 April 2018 - P2464
Whole-genome sequence analysis of the first plasmid-mediated colistin resistance MCR-1 Salmonella serotype Choleraesuis in Spain, 2016
Silvia Herrera-Leon, S. Monzon, C. Navarro San Francisco, M. Llorente, S. Sanchez, I. Cuesta de la Plaza, S. Herrera-Leon
23 April 2018 - P1802
Effect on antibiotic prescription of direct antimicrobial susceptibility testing from pellets obtained in MALDI-TOF identification of Gram-negative bacilli from positive blood cultures
José María López-Pintor, J. López-Pintor, J. Sánchez López, C. Navarro San Francisco, M. Morosini Reilly, E. Loza, R. Canton Moreno
21 April 2018 - P0405
Detection of colistin-resistant Enterobacteriaceae recovered from human, veterinary and sewage sources with the Rapid Polymyxin NP Test
Maria-Isabel Morosini Reilly, M. Morosini Reilly, J. Delgado Blas, C. Navarro San Francisco, A. Halperin, G. Moyano, B. Gonzalez-Zorn, R. Canton Moreno
09 April 2016 - E083
An ESBL-colonized patient with signs of infection in an emergency room
Carolina Navarro-San Francisco
30 April 2013 - O663
The presence of the fyuA and P fimbria genes are related with mortality in Escherichia coli bloodstream infections
Marta Mora-Rillo, M. Mora-Rillo*, N. Fernández-Romero, C. Navarro-San Francisco, M.P. Romero-Gómez, J.R. Paño-Pardo, J.R. Arribas-López, J. Mingorance (Madrid, ES)
28 April 2013 - P1636
Low airborne concentrations following simulated amikacin inhale delivery during on-ventilator and handheld use
Kevin Corkery, K.J. Corkery*, R. Bacci, N. Kadrichu (San Carlos, San Francisco, US)
28 April 2013 - P1637
A double-blind, randomized, placebo-controlled study to assess the safety, tolerability, plasma pharmacokinetics and lung penetration of intravenous plazomicin in healthy subjects
Corwin Kostrub, R. Cass, C. Kostrub, M. Gotfried, K. Rodvold, K. Tack, J. Bruss* (San Francisco, Phoenix, Cincinnati, US)
28 April 2013 - LB2961
Plazomicin demonstrates potent efficacy against carbapenem-resistant Enterobacteriaceae (CRE) in the neutropenic mouse thigh infection model
Corwin Kostrub, A. Louie*, C. Kostrub, S. Fikes, W. Liu, L.A. Feeney, L. Connolly, G. Drusano (Orlando, San Francisco, US)
27 April 2013 - P918
The pharmacokinetics (PK) and safety of plazomicin in subjects with renal impairment
Todd Clobes, V. Riddle, D. Cebrik, C. Kostrub, L. Ma*, K. Hillan (Crofton, San Francisco, South San Francisco, US)
27 April 2013 - R2606
Telavancin in combination with other broad-spectrum agents has no impact on the in vitro activity of these agents against prevalent Gram-negative pathogens
Dean Shinabarger, C.M. Pillar*, D. Sweeney, N. Nichols, G. Zurenko, B.M. Benton (Kalamazoo, San Francisco, US)
27 April 2013 - P916
Pharmacokinetic-pharmacodynamic (PK-PD) analyses for efficacy and safety of brilacidin (BRI) using data from patients with acute bacterial skin and skin structure infections (ABSSSI)
Sujata M. Bhavnani, S.M. Bhavnani*, J.P. Hammel, A. Forrest, M. Melhem, P. Sager, D.M. Jorgensen, P.G. Ambrose (Latham, San Francisco, Radnor, US)
27 April 2013 - P915
Use of pharmacokinetics-pharmacodynamics (PK-PD) and Monte Carlo simulation (MCS) analyses to support brilacidin (BRI) dose selection for patients with acute bacterial skin and skin structure infections (ABSSSI)
Sujata M. Bhavnani, S.M. Bhavnani*, J.P. Hammel, A. Forrest, M. Melhem, P. Sager, K.J. Tack, P.G. Ambrose, D.M. Jorgensen (Latham, San Francisco, Brighton, Radnor, US)
27 April 2013 - P914
Pharmacokinetic-pharmacodynamics (PK-PD) predict a high probability of efficacy for plazomicin against serious infections caused by carbapenem-resistant Enterobacteriaceae (CRE)
Sujata M. Bhavnani, S.A. Van Wart, A. Forrest, G.L. Drusano, S.M. Bhavnani*, C.C. Bulik, C.F. Kostrub, P.G. Ambrose, A. Louie (Latham, Orlando, South San Francisco, US)
27 April 2013 - O170
Phenol-soluble modulins act as intracellular toxins in community-acquired methicillin-resistant Staphylococcus aureus (MRSA)
Jean-Philippe Rasigade, J.P. Rasigade*, A. Sapin, S. Trouillet, B.A. Diep, F. Vincent, T. Ferry, J. Etienne, G. Lina, F. Vandenesch, F. Laurent (Lyon, FR; San Francisco, US)
02 April 2012 - O497
Clinical features and outcome of 26 bloodstream infections (BSI) caused by OXA-48 producing Enterobacteriaceae in a university hospital in Spain
Carolina Navarro San Francisco, C. Navarro San Francisco, M. Mora Rillo, M.P. Romero Gómez, A. Rico Nieto, S. Caro Bragado, F. Moreno Ramos, G. Ruiz Carrascoso, C.I. Soto Abanades, R. Gomez Gil, J. García Rodriguez, J.R. Arribas López, J.R. Paño Pardo* (Madrid, ES)
02 April 2012 - LB2816
Comparison of tedizolid phosphate and linezolid in investigator’s assessment of clinical response in patients with cellulitis in United States and Europe from a phase 3 ABSSSI study
Brendan Hannah, C. De Anda*, E. Fang, A. Das, M.C. Morillo, P. Prokocimer (San Diego, San Francisco, US; Ascot, UK)
31 March 2012 - P693
Assessment of two early-response outcome measures in a phase 2 clinical trial of the pleuromutilin BC-3781 in acute bacterial skin and skin structure infections
George Talbot, W. Prince, F. Obermayr, C. Lell, A. Das, G. Talbot* (Vienna, AT; San Francisco, Anna Maria, US)
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.